Literature DB >> 20130732

Role of the RhoA/Rho-kinase pathway in the regulation of pulmonary vasoconstrictor function.

Bobby D Nossaman1, Vaughn E Nossaman, Subramanyam N Murthy, Philip J Kadowitz.   

Abstract

Calcium is the major intracellular messenger that triggers smooth muscle contraction. The study of calcium-binding proteins, such as calmodulin and its downstream effectors, reveals critical regulation of smooth muscle contraction by protein kinases and phosphatases. Moreover, the small GTP-binding protein RhoA and its downstream effector protein, Rho-kinase, have been shown to play a novel role in the regulation of smooth muscle contraction. Studies have shown that the activation of Rho-kinase is involved in the development of endothelial dysfunction, inflammation, restenosis, and increased vascular tone in a number of cardiovascular disorders. Because inhibitors of this pathway promote vasodilation independent of the mechanism that increases vasoconstrictor tone, it is our hypothesis that Rho-kinase is constitutively active in regulating vasoconstrictor tone in the pulmonary and systemic vascular beds. Studies in the literature suggest that the RhoA/Rho-kinase pathway has an important role in the pathogenesis of pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20130732     DOI: 10.1139/Y09-092

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  3 in total

1.  Arsenite activates NFκB through induction of C-reactive protein.

Authors:  Ingrid L Druwe; James J Sollome; Pablo Sanchez-Soria; Rhiannon N Hardwick; Todd D Camenisch; Richard R Vaillancourt
Journal:  Toxicol Appl Pharmacol       Date:  2012-04-12       Impact factor: 4.219

2.  Stimulators of soluble guanylyl cyclase: future clinical indications.

Authors:  Bobby D Nossaman; Philip J Kadowitz
Journal:  Ochsner J       Date:  2013

Review 3.  Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.

Authors:  Satyan Lakshminrusimha; Bobby Mathew; Corinne L Leach
Journal:  Semin Perinatol       Date:  2016-01-14       Impact factor: 3.300

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.